Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
137.5 GBX | -1.79% | -7.09% | -54.92% |
Mar. 19 | Transcript : Faron Pharmaceuticals Oy - Special Call | |
Mar. 18 | Stocks downbeat before central bank rate storm | AN |
Sales 2023 | - | Sales 2024 * | 18M 19.43M | Capitalization | 112M 121M |
---|---|---|---|---|---|
Net income 2023 | -30M -32.38M | Net income 2024 * | -6M -6.48M | EV / Sales 2023 | - |
Net Debt 2023 | 6.02M 6.5M | Net Debt 2024 * | 13.43M 14.5M | EV / Sales 2024 * | 6.99 x |
P/E ratio 2023 * |
-5.27
x | P/E ratio 2024 * |
-7.78
x | Employees | 34 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 58.18% |
Latest transcript on Faron Pharmaceuticals Oy
1 day | -3.57% | ||
1 week | -8.78% | ||
Current month | +5.88% | ||
1 month | +8.00% | ||
3 months | -58.33% | ||
6 months | -57.14% | ||
Current year | -55.74% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 02-12-31 | |
Founder | 46 | 02-12-31 | |
Founder | 70 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Armstrong
CHM | Chairman | 67 | 15-09-15 |
Founder | 70 | 02-12-31 | |
Director/Board Member | 60 | 23-03-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 137.5 | -1.79% | 14 979 |
24-03-27 | 140 | -1.75% | 10,515 |
24-03-26 | 142.5 | -1.72% | 89,665 |
24-03-25 | 145 | 0.00% | 41,486 |
24-03-22 | 145 | -2.03% | 23,497 |
Delayed Quote London S.E., March 28, 2024 at 04:26 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.74% | 122M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.71% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |